Literature DB >> 26730164

Liver metastasis from hepatoid adenocarcinoma of the stomach mimicking hepatocellular carcinoma: Dynamic computed tomography findings.

Yang-Yu Lin1, Chien-Ming Chen1, Yu-Hsiu Huang1, Cheng-Yu Lin1, Sung-Yu Chu1, Ming-Yi Hsu1, Kuang-Tse Pan1, Jeng-Hwei Tseng1.   

Abstract

AIM: To evaluate the dynamic computed tomography (CT) findings of liver metastasis from hepatoid adenocarcinoma of the stomach (HAS) and compared them with hepatocellular carcinoma (HCC).
METHODS: Between January 2000 and January 2015, 8 patients with pathologically proven HAS and liver metastases were enrolled. Basic tumor status was evaluated for the primary tumor location and metastatic sites. The CT findings of the liver metastases were analyzed for tumor number and size, presence of tumor necrosis, hemorrhage, venous tumor thrombosis, and dynamic enhancing pattern.
RESULTS: The body and antrum were the most common site for primary HAS (n = 7), and observed metastatic sites included the liver (n = 8), lymph nodes (n = 7), peritoneum (n = 4), and lung (n = 2). Most of the liver metastases exhibited tumor necrosis regardless of tumor size. By contrast, tumor hemorrhage was observed only in liver lesions larger than 5 cm (n = 4). Three patterns of venous tumor thrombosis were identified: direct venous invasion by the primary HAS (n = 1), direct venous invasion by the liver metastases (n = 7), and isolated portal vein tumor thrombosis (n = 2). Dynamic CT revealed arterial hyperattenuation and late phase washout in all the liver metastases.
CONCLUSION: On dynamic CT, liver metastasis from HAS shared many imaging similarities with HCC. For liver nodules, the presence of isolated portal vein tumor thrombosis and a tendency for tumor necrosis are imaging clues that suggest the diagnosis of HAS.

Entities:  

Keywords:  Computed tomography; Hepatocellular carcinoma; Hepatoid adenocarcinoma; Liver; Stomach

Mesh:

Year:  2015        PMID: 26730164      PMCID: PMC4690182          DOI: 10.3748/wjg.v21.i48.13524

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  Upper abdominal lymph nodes: criteria for normal size determined with CT.

Authors:  R E Dorfman; M B Alpern; B H Gross; M A Sandler
Journal:  Radiology       Date:  1991-08       Impact factor: 11.105

2.  Hydro-dynamic CT preoperative staging of gastric cancer: correlation with pathological findings. A prospective study of 107 cases.

Authors:  F D'Elia; A Zingarelli; D Palli; M Grani
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

3.  Anechoic halo in solid liver tumors: sonographic, microangiographic, and histologic correlation.

Authors:  G J Marchal; K Pylyser; E A Tshibwabwa-Tumba; E K Verbeken; R H Oyen; A L Baert; J M Lauweryns
Journal:  Radiology       Date:  1985-08       Impact factor: 11.105

4.  Benign and malignant portal vein thrombosis: differentiation by CT characteristics.

Authors:  M E Tublin; G D Dodd; R L Baron
Journal:  AJR Am J Roentgenol       Date:  1997-03       Impact factor: 3.959

5.  Alpha-Fetoprotein-Producing Extrahepatic Tumor: Clinical and Histopathological Significance of a Case.

Authors:  Jose A Nuevo-Gonzalez; Juan C Cano-Ballesteros; Beatriz Lopez; Juan A Andueza-Lillo; Luis Audibert
Journal:  J Gastrointest Cancer       Date:  2012-09

6.  Pathological evaluation of hepatic dearterialization in encapsulated hepatocellular carcinoma.

Authors:  N Tanaka; E Okamoto; A Toyosaka; S Fujiwara
Journal:  J Surg Oncol       Date:  1985-08       Impact factor: 3.454

Review 7.  Hemoperitoneum in patients with ascites.

Authors:  E A Akriviadis
Journal:  Am J Gastroenterol       Date:  1997-04       Impact factor: 10.864

8.  Recurrence of hepatocellular carcinoma with rapid growth after spontaneous regression.

Authors:  Tomoki Nakajima; Michihisa Moriguchi; Tadashi Watanabe; Masao Noda; Nobuaki Fuji; Masahito Minami; Yoshito Itoh; Takeshi Okanoue
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

9.  Spontaneous rupture of hepatocellular carcinoma. A review of 141 Taiwanese cases and comparison with nonrupture cases.

Authors:  C Y Chen; X Z Lin; J S Shin; C Y Lin; T C Leow; C Y Chen; T T Chang
Journal:  J Clin Gastroenterol       Date:  1995-10       Impact factor: 3.062

10.  Venous tumor thrombosis and cavernous transformation of the portal vein in a patient with gastric carcinoma.

Authors:  M Ishikawa; S Koyama; T Ikegami; H Fukutomi; T Gohongi; K Yuzawa; K Fukao; M Fujiwara; K Fujii
Journal:  J Gastroenterol       Date:  1995-08       Impact factor: 7.527

View more
  5 in total

1.  Clinicopathological Characteristics and Prognosis of Hepatoid Adenocarcinoma of the Stomach: Evaluation of a Pooled Case Series.

Authors:  Xiang-Yu Zeng; Yu-Ping Yin; Hua Xiao; Peng Zhang; Jun He; Wei-Zhen Liu; Jin-Bo Gao; Xiao-Ming Shuai; Guo-Bin Wang; Xiu-Li Wu; Kai-Xiong Tao
Journal:  Curr Med Sci       Date:  2018-12-07

Review 2.  Therapeutic Approaches to Gastric Hepatoid Adenocarcinoma: Current Perspectives.

Authors:  Jon Arne Søreide
Journal:  Ther Clin Risk Manag       Date:  2019-12-23       Impact factor: 2.423

Review 3.  Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments.

Authors:  Ruolan Xia; Yuwen Zhou; Yuqing Wang; Jiaming Yuan; Xuelei Ma
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

4.  MRI features of hepatic metastasis from hepatoid adenocarcinoma of the stomach: A case report.

Authors:  Jie Yuan; Guonian Wang; Mengxiao Liu; Zhigang Gong
Journal:  Radiol Case Rep       Date:  2022-05-05

5.  Integrative analysis reveals a clinicogenomic landscape associated with liver metastasis and poor prognosis in hepatoid adenocarcinoma of the stomach.

Authors:  Junjie Jiang; Yongfeng Ding; Jun Lu; Yanyan Chen; Yiran Chen; Wenyi Zhao; Wenfan Chen; Mei Kong; Chengzhi Li; Xiaodong Teng; Quan Zhou; Nong Xu; Donghui Zhou; Zhan Zhou; Haiyong Wang; Lisong Teng
Journal:  Int J Biol Sci       Date:  2022-08-29       Impact factor: 10.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.